Prior authorization — the requirement that healthcare providers obtain approval from a health insurance company before delivering specific services — has long been criticized for creating bottlenecks in care. Critics argue that lengthy wait times for approval can result in worsening health conditions, higher costs, and even preventable medical emergencies.
Senate Bill 133 received unanimous support in both chambers of the Alaska Legislature, reflecting a rare bipartisan consensus on healthcare reform. The law officially takes effect for enforcement on January 1, 2026, although insurers and regulators are expected to begin preparing immediately to meet the new standards.
“This legislation puts patients first,” said Senator Cathy Giessel, a sponsor of the bill. “We heard from countless Alaskans who experienced harmful delays in care due to insurance red tape. With this new law, we are holding insurers accountable and ensuring that medically necessary treatments are not stuck in limbo.”
The law includes provisions to accommodate complex cases. Insurers can request additional information from providers within 14 business days if more documentation is needed to make a decision. However, they must do so promptly and still meet the overall deadlines.
Importantly, the law carves out exceptions for specific circumstances. For instance, it exempts certain requirements for generic drug prescriptions and modifies rules around step therapy protocols for cancer patients — allowing for faster access to advanced or alternative therapies without requiring patients to first “fail” on older or cheaper treatments.
Medical professionals have largely welcomed the new rules. “This is a win for patient safety,” said Dr. Michael Burton, a physician based in Anchorage. “Waiting days or even weeks for approval has put our patients at risk. This law will allow us to treat patients more efficiently and with fewer barriers.”
On the insurance side, industry representatives have expressed cautious optimism. While insurers are concerned about operational burdens and staffing needed to comply with the shorter turnaround times, they acknowledge the intent behind the law and have committed to working with regulators during implementation.
Healthcare access in rural and underserved communities, which are common in Alaska, is expected to benefit significantly. In these areas, where specialist visits and procedures often involve travel and scheduling logistics, delays in prior authorizations can have amplified consequences.
